Systemic sclerosis (scleroderma): open trials in South Korea

2 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07641634
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Trial Treatment · Phase 1/2 · Prolium Bioscience, Inc
Seoul National University Hospital, Seoul · Kyung Hee University Hospital, Seoul
Registry updated 2026-10-09
NCT05878717
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Trial Treatment · Phase 2/3 · GlaxoSmithKline
GSK Investigational Site, Seoul · GSK Investigational Site, Suwon Kyunggi-do
Registry updated 2026-09-08

This page is not medical advice. Talk to your doctor before contacting a trial.

A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.